Basic Information
BrainVectis Develops Gene Therapies for Neurodegenerative Diseases by Targeting Cholesterol Pathways in the Brain
BrainVectis
Ile-de-France,France
less than 15 people
January 01, 2015
--
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios